Association Between Clonal Hematopoiesis and Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy

Shunsuke Inoue,Toshiyuki Ko,Akito Shindo,Seitaro Nomura,Takanobu Yamada,Takahiro Jimba,Zhehao Dai,Harumi Nakao,Atsushi Suzuki,Takeshi Kashimura,Togo Iwahana,Keiko Goto,Shouji Matsushima,Junichi Ishida,Eisuke Amiya,Bo Zhang,Masayuki Kubota,Kosuke Sawami,Tuolisi Heryed,Shintaro Yamada,Manami Katoh,Mikako Katagiri,Masamichi Ito,Yukiteru Nayakama,Katsuhito Fujiu,Masaru Hatano,Norifumi Takeda,Eiki Takimoto,Hiroshi Akazawa,Hiroyuki Morita,Junichi Yamaguchi,Takayuki Inomata,Yoshio Kobayashi,Tohru Minamino,Hiroyuki Tsutsui,Mineo Kurokawa,Atsu Aiba,Hiroyuki Aburatani,Issei Komuro

DOI: https://doi.org/10.1016/j.jacbts.2024.04.010

2024-06-12

Abstract:Although clonal hematopoiesis of indeterminate potential (CHIP) is an adverse prognostic factor for atherosclerotic disease, its impact on nonischemic dilated cardiomyopathy (DCM) is elusive. The authors performed whole-exome sequencing and deep target sequencing among 198 patients with DCM and detected germline mutations in cardiomyopathy-related genes and somatic mutations in CHIP driver genes. Twenty-five CHIP driver mutations were detected in 22 patients with DCM. Ninety-two patients had cardiomyopathy-related pathogenic mutations. Multivariable analysis revealed that CHIP was an independent risk factor of left ventricular reverse remodeling, irrespective of known prognostic factors. CHIP exacerbated cardiac systolic dysfunction and fibrosis in a DCM murine model. The identification of germline and somatic mutations in patients with DCM predicts clinical prognosis.